Trinity Biotech PLC
NASDAQ:TRIB
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.09
3.46
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one TRIB stock under the Base Case scenario is 7.25 USD. Compared to the current market price of 1.67 USD, Trinity Biotech PLC is Undervalued by 77%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Trinity Biotech PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for TRIB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Trinity Biotech PLC
Balance Sheet Decomposition
Trinity Biotech PLC
Current Assets | 46m |
Cash & Short-Term Investments | 5.3m |
Receivables | 17.7m |
Other Current Assets | 23m |
Non-Current Assets | 48.4m |
PP&E | 3.9m |
Intangibles | 41.8m |
Other Non-Current Assets | 2.7m |
Current Liabilities | 25.8m |
Accounts Payable | 23.1m |
Other Current Liabilities | 2.7m |
Non-Current Liabilities | 98m |
Long-Term Debt | 91m |
Other Non-Current Liabilities | 7m |
Earnings Waterfall
Trinity Biotech PLC
Revenue
|
58.7m
USD
|
Cost of Revenue
|
-38.5m
USD
|
Gross Profit
|
20.1m
USD
|
Operating Expenses
|
-34.7m
USD
|
Operating Income
|
-14.6m
USD
|
Other Expenses
|
-7.7m
USD
|
Net Income
|
-22.3m
USD
|
Free Cash Flow Analysis
Trinity Biotech PLC
USD | |
Free Cash Flow | USD |
Trinity Biotech experienced a significant quarter with revenues reaching $15.8 million, up 14% year-over-year. Point-of-care sales more than doubled, driven by the successful scaling of TrinScreen HIV, which generated $3.1 million, aligning with projections for $8 million in 2024. An impressive 50% quarter-on-quarter growth and a 45% increase in operating profitability underpinned ongoing efficiencies. The company anticipates annualized revenues of approximately $75 million and EBITDASO of $20 million by Q2 2025. Additionally, progress in their continuous glucose monitoring technologies promises future growth, with clinical trials slated for completion within the next year.
What is Earnings Call?
TRIB Profitability Score
Profitability Due Diligence
Trinity Biotech PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
Trinity Biotech PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
TRIB Solvency Score
Solvency Due Diligence
Trinity Biotech PLC's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Score
Trinity Biotech PLC's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TRIB Price Targets Summary
Trinity Biotech PLC
Dividends
Current shareholder yield for TRIB is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.
Contact
IPO
Employees
Officers
The intrinsic value of one TRIB stock under the Base Case scenario is 7.25 USD.
Compared to the current market price of 1.67 USD, Trinity Biotech PLC is Undervalued by 77%.